| Charles C Dumontier, MD | |
|
180 South Third Street, Suite 101, Belleville, IL 62220 | |
| (618) 235-0651 | |
| (618) 235-9722 |
| Full Name | Charles C Dumontier |
|---|---|
| Gender | Male |
| Speciality | Radiology - Diagnostic Radiology |
| Location | 180 South Third Street, Belleville, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215981519 | NPI | - | NPPES |
| L95013 | Other | MEDICARE PIN | |
| 141550 | Other | HEALTHLINK | |
| 36066819 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 036066819 (Illinois) | Primary |
| 2085R0202X | Radiology - Diagnostic Radiology | R9A58 (Missouri) | Secondary |
| Entity Name | Touchette Regional Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922019926 PECOS PAC ID: 7416843370 Enrollment ID: O20040226000538 |
News Archive
Every year, more than 59,000 people around the world die of rabies and there remains no cheap and easy vaccine regimen to prevent the disease in humans. Now, researchers report in PLOS Neglected Tropical Diseases that adding a specific immune molecule to a rabies vaccine can boost its efficacy.
The Sunnyvale, Calif.-based company Cepheid on Tuesday announced it has developed a rapid diagnostic test for tuberculosis that it will sell at a reduced cost in developing countries, the San Francisco Chronicle reports. The test was developed in partnership with the Foundation for Innovative New Diagnostics, the University of Medicine and Dentistry of New Jersey, and the National Institute of Allergy and Infectious Diseases.
Researchers have discovered that a virus-like particle vaccine can prime the body's immune response and prevent the severe respiratory disease that results when patients given an early form of a vaccine for respiratory syncytial virus (RSV) are exposed to RSV, according to a study led by Georgia State University.
AbbVie, a global biopharmaceutical company, today announced data showing that patients with genotype 1 (GT1) chronic hepatitis C virus (HCV) infection who received the recommended regimen of VIEKIRAX (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA (dasabuvir tablets), with or without ribavirin (RBV), achieved high sustained virologic response rates at 48 weeks post-treatment (SVR48), regardless of the presence of baseline resistance-associated variants (RAVs).
According to researchers, women with a large bra size at a young age are more likely to develop pre-menopausal breast cancer.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Charles C Dumontier, MD 301 West Lincoln Street, Suite 104, Belleville, IL 62220 Ph: (618) 235-0955 | Charles C Dumontier, MD 180 South Third Street, Suite 101, Belleville, IL 62220 Ph: (618) 235-0651 |
News Archive
Every year, more than 59,000 people around the world die of rabies and there remains no cheap and easy vaccine regimen to prevent the disease in humans. Now, researchers report in PLOS Neglected Tropical Diseases that adding a specific immune molecule to a rabies vaccine can boost its efficacy.
The Sunnyvale, Calif.-based company Cepheid on Tuesday announced it has developed a rapid diagnostic test for tuberculosis that it will sell at a reduced cost in developing countries, the San Francisco Chronicle reports. The test was developed in partnership with the Foundation for Innovative New Diagnostics, the University of Medicine and Dentistry of New Jersey, and the National Institute of Allergy and Infectious Diseases.
Researchers have discovered that a virus-like particle vaccine can prime the body's immune response and prevent the severe respiratory disease that results when patients given an early form of a vaccine for respiratory syncytial virus (RSV) are exposed to RSV, according to a study led by Georgia State University.
AbbVie, a global biopharmaceutical company, today announced data showing that patients with genotype 1 (GT1) chronic hepatitis C virus (HCV) infection who received the recommended regimen of VIEKIRAX (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA (dasabuvir tablets), with or without ribavirin (RBV), achieved high sustained virologic response rates at 48 weeks post-treatment (SVR48), regardless of the presence of baseline resistance-associated variants (RAVs).
According to researchers, women with a large bra size at a young age are more likely to develop pre-menopausal breast cancer.
› Verified 6 days ago
Robert Barton Bridges, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 34 Powder Valley Dr, Belleville, IL 62223 Phone: 618-580-3750 Fax: 618-397-5494 | |
Gregory P Holdener, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 301 West Lincoln Street, Suite 104, Belleville, IL 62220 Phone: 618-235-0955 Fax: 618-235-9203 | |
Terrence A Tyrrell, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 180 South Third Street, Suite 101, Belleville, IL 62220 Phone: 618-235-0651 Fax: 618-235-9722 | |
Dean David Hageman, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1416 Prairie Ave, Belleville, IL 62220 Phone: 618-235-5998 | |
Dr. Naveen C. Saini, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 301 West Lincoln Street, Suite 104, Belleville, IL 62220 Phone: 618-235-0955 Fax: 618-235-9203 | |
Paul M Schroeder, MD Radiology Medicare: Medicare Enrolled Practice Location: 301 West Lincoln Street, Suite 104, Belleville, IL 62220 Phone: 618-235-0955 Fax: 618-235-9203 |